title: First case of Legionella pneumophila native valve endocarditis.
abstract: We report the first case in the English language literature, to our knowledge, of native valve endocarditis due to Legionella pneumophila. The patient had no prior history of cardiothoracic intervention or congenital valvular process. A transesophageal echocardiogram showed a vegetation on the aortic valve. Blood culture and bronchoalveolar lavage returned positive for L. pneumophila. The patient was treated with levofloxacin for 6 weeks total after a second set of blood cultures were negative. The patient survived a complicated hospital course and was discharged to a rehabilitation facility.
authors.affiliation: University of Florida, Health Science Center Jacksonville, 655 West 8th Street, Jacksonville, FL 32209, USA. samuelvinny@hotmail.com
authors.forename: Vinny
authors.initials: V
authors.lastname: Samuel
authors.forename: Abubakr A
authors.initials: AA
authors.lastname: Bajwa
authors.forename: James D
authors.initials: JD
authors.lastname: Cury
mesh_terms: D000328:Adult; D001021:Aortic Valve / Q000382:microbiology*; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016952:Legionella pneumophila / Q000187:drug effects / Q000302:isolation & purification*; D064704:Levofloxacin; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D064704:Levofloxacin; D015242:Ofloxacin; D012293:Rifampin